Pictet Asset Management
ZYME icon

Pictet Asset Management’s Zymeworks ZYME Stock Holding History

Pictet Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$232K Sell
9,256
-64,371
-87% -$1.52M ﹤0.01% 1870
2025
Q4 		$1.97M Buy
+73,627
New +$1.61M ﹤0.01% 907

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management's ZYME Position: Q1 2026 in Review

Pictet Asset Management reduced its Zymeworks (ZYME) stake by 87% in Q1 2026, selling an estimated $1.52M and leaving 9,256 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Pictet Asset Management first reported a position in ZYME in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.97M in Q4 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Pictet Asset Management held 9,256 shares of Zymeworks worth $232K as of Q1 2026.
  • Pictet Asset Management sold 64,371 Zymeworks shares in Q1 2026, an estimated $1.52M.
  • Zymeworks made up ﹤0.01% of Pictet Asset Management's portfolio in Q1 2026, its #1870 holding.
  • Pictet Asset Management first reported a position in Zymeworks in Q4 2025 and has held it in 2 quarters since.
  • Pictet Asset Management's Zymeworks position peaked at $1.97M in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.